| Year |
Citation |
Score |
| 2018 |
Tzeng SF, Tsai CH, Chao TK, Chou YC, Yang YC, Tsai MH, Cha TL, Hsiao PW. O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800687. PMID 29906246 DOI: 10.1096/fj.201800687 |
0.312 |
|
| 2015 |
Cha TL, Chuang MJ, Tang SH, Wu ST, Sun KH, Chen TT, Sun GH, Chang SY, Yu CP, Ho JY, Liu SY, Huang SM, Yu DS. Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Molecular Carcinogenesis. 54: 167-77. PMID 24115089 DOI: 10.1002/mc.22084 |
0.388 |
|
| 2013 |
Chuang MJ, Wu ST, Tang SH, Lai XM, Lai HC, Hsu KH, Sun KH, Sun GH, Chang SY, Yu DS, Hsiao PW, Huang SM, Cha TL. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. Plos One. 8: e73401. PMID 24023871 DOI: 10.1371/journal.pone.0073401 |
0.411 |
|
| 2005 |
Cha TL, Zhou BP, Xia W, Wu Y, Yang CC, Chen CT, Ping B, Otte AP, Hung MC. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science (New York, N.Y.). 310: 306-10. PMID 16224021 DOI: 10.1126/science.1118947 |
0.351 |
|
| 2005 |
Rau KM, Kang HY, Cha TL, Miller SA, Hung MC. The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocrine-Related Cancer. 12: 511-32. PMID 16172190 DOI: 10.1677/erc.1.01026 |
0.39 |
|
| 2005 |
Cha TL, Qiu L, Chen CT, Wen Y, Hung MC. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research. 65: 2287-95. PMID 15781642 DOI: 10.1158/0008-5472.Can-04-3250 |
0.492 |
|
| Show low-probability matches. |